Erythema - 149 Studies Found

Completed : MSC2364447C Phase 1b in Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2015-08-28
:
  • Drug: MSC2364447C Subjects wil
Completed : Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2004-02-02
:
  • Drug: fludarabine phosphate Co
Completed : Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2001-01-16
Completed : Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2007-12-19
Completed : Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2008-07-08
: Drug: SBI-087 Single IV or SC dose of SBI-087
Completed : Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2013-10-24
:
  • Drug: Atacicept 75 milligram (mg)

Completed : Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2008-01-28
:
  • Biological: Prevenar® and Pneumo23®

Completed : Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)
: Lupus Erythematosus, Systemic
: 2008-02-15
:
  • Drug: Atacicept 75 mg 75 milli
Recruiting : TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment
: Lupus Erythematosus, Systemic
: 2016-03-14
:
  • Drug: TAB08 biologic
Terminated : A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
: Lupus Erythematosus, Systemic
: 2006-09-26
:
  • Drug: Rituximab Rituximab will
<<< Previous | Next >>>